Transvaginal Mesh Study Concludes

The Food and Drug Administration (“FDA”) recently released results of a post-market surveillance study on vaginal mesh devices. The devices are manufactured by Coloplast and used to treat pelvic organ prolapse. The devices at issue were discontinued years ago after numerous reports of negative outcomes. But the FDA required the manufacturer, Coloplast, to complete a study already underway at the time the products were discontinued. The FDA determined again the devices carry additional risks compared to other methods of treating pelvic organ prolapse. It maintained that the benefits of the product do not outweigh the risks. The results can be found here: FDA’s Activities: Urogynecologic Surgical Mesh | FDA

Adderall Shortage in the U.S.

Adderall is a prescription drug used to treat ADHD (attention deficit hyperactivity disorder). The FDA has declared a nationwide shortage on the drug because of manufacturing delays. Nine companies manufacture Adderall and most is manufactured by Teva. Patients are advised to work with their health care provider to discuss lowering their dosage or obtaining another version of the medication. Read the FDA’s announcement on the shortage here: FDA Announces Shortage of Adderall | FDA

Consumer Update on February 2022 Recall of Abbott Baby Formula

The FDA issued a Consumer Update regarding the risk of Cronobacter sakazakii in infant formula. It is a follow up to a recall earlier this year of certain powder baby formulas manufactured by Abbott. The formulas contained Cronobacter sakazakii which can lead to serious illness. The recalled products were manufactured at Abbott’s facility in Sturgis, Michigan and include Similac, Alimentum and Elecare. The Update is meant to help consumers understand and minimize the risks. Read the Consumer Update here: What to Know About the Risk of Cronobacter in Powdered Infant Formula | FDA

More Abbott Baby Formula Recalled

Baby formula manufacturer, Abbott, has recalled a small number of lots of its Ready-to Feed liquid products. The formula was recalled because bottle caps may not have sealed completely and may spoil. This could lead to gastrointestinal problems. The products were manufactured at Abbott’s manufacturing facility in Columbus, Ohio.  Detailed information can be found here: Abbott Voluntarily Recalls Certain Lots of 2 Fl. Oz./59 mL Bottles of Ready-to-Feed Liquid Products; Recall Is Not Expected to Impact U.S. Infant Formula Supply | FDA

OUR team

We prefer doing to talking (except in court), We take the bull by the horns and give you clear and practical advice. Personal, to the point, and in plain language. Any questions? Feel free to call or to drop by.

After reviewing your medical costs, lost wages, and pain and suffering damages, we can help you understand what your case is worth and plan a road map going forward.
After reviewing your medical costs, lost wages, and pain and suffering damages, we can help you understand what your case is worth and plan a road map going forward.

$1.056 billion verdict against Exxon Mobil

If you think you may have a claim and need legal help to hold those parties responsible for damage that they have caused, contact an attorney from our firm.

Stag Liuzza fights industry giants across the country and holds them accountable for their actions. We strive to ensure that communities have access to safe drinking water, clean air, and a healthy environment.

stagliuzza.com is operated and provided by Stag Liuzza, LLC responsible attorneys Michael G. Stag and Ashley M. Liuzza. Stag Liuzza, LLC is officed in New Orleans, LA, and our attorneys are licensed in Louisiana and Mississippi.

Nothing on this site should be taken to establish an attorney-client relationship with us unless and until a contract for representation is signed. The attorneys of Stag Liuzza are licensed in Louisiana and Mississippi and may associate counsel licensed in other jurisdictions as necessary.

Past results do not guarantee any similar result or outcome in your claim. Each claim is different.

This website uses cookies to ensure you get the best experience on our website.